Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose
试验速览
- 阶段
- 4 期
- 入组人数
- 160
- 试验地点
- 1
- 主要终点
- Rabies antibody titer
研究概览
简要总结
This study is to investigate the persistence of rabies Chinese manufactured antibody 1-5 years after the post-exposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose. A total of 160 subjects would be enrolled. These subjects were all administered ChengDa antirabies vaccine from 2005 to 2009. After informed consent is obtained, these subjects would be tested for their antirabies antibody titer and given a single booster dose. Seven and 14 days later, the investigators would re-evaluate the antibody titer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •20 to 60 years old
- •Given ChengDa rabies vaccine
- •Good compliance
- •Obtained informed consent
排除标准
- •Other than inclusion criteria
研究组 & 干预措施
Post vaccination
All the subjects had been vaccinated with antirabies vaccine.
干预措施: Rabies vaccine, manufactured by ChengDa (Biological)
结局指标
主要结局
Rabies antibody titer
时间窗: 6 months
We test the antirabies antibody titer before and after the single booster dose
次要结局
未报告次要终点